{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["indole-based phenylallylidene derivatives", "kinetics", "molecular docking", "monoamine oxidase inhibitors", "neurological diseases", "neuroprotection", "reversibility"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37630420", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "21"}], "Language": ["eng"], "ELocationID": ["6167", "10.3390/molecules28166167"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "16", "PubDate": {"Year": "2023", "Month": "Aug", "Day": "21"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.", "Abstract": {"AbstractText": ["Monoamine oxidase (MAO, EC 1.4.3.4) is responsible for the oxidative breakdown of both endogenous and exogenous amines and exists in MAO-A and MAO-B isomers. Eighteen indole-based phenylallylidene derivatives were synthesized via nucleophilic addition reactions comprising three sub-series, <b>IHC</b>, <b>IHMC</b>, and <b>IHNC</b>, and were developed and examined for their ability to inhibit MAO. Among them, compound <b>IHC3</b> showed a strong MAO-B inhibitory effect with an IC<sub>50</sub> (<i>half-maximal inhibitory concentration</i>) value of 1.672 \u03bcM, followed by <b>IHC2</b> (IC<sub>50</sub> = 16.934 \u03bcM). Additionally, <b>IHC3</b> showed the highest selectivity index (SI) value of >23.92. The effectiveness of <b>IHC3</b> was lower than the reference pargyline (0.14 \u03bcM); however, the SI value was higher than pargyline (17.16). Structurally, the <b>IHC</b> (-H in the B-ring) sub-series exhibited relatively stronger MAO-B inhibition than the others. In the <b>IHC</b> series, <b>IHC3</b> (-F in the A-ring) exhibited stronger MAO-B suppression than the other substituted derivatives in the order -F > -Br > -Cl > -OCH<sub>3</sub>, -CH<sub>3</sub>, and -H at the 2-position in the A-ring. In the reversibility and enzyme kinetics experiments, <b>IHC3</b> was a reversible inhibitor with a K<sub>i</sub> value of 0.51 \u00b1 0.15 \u03bcM for MAO-B. Further, it was observed that <b>IHC3</b> greatly decreased the cell death caused by rotenone in SH-SY5Y neuroblastoma cells. A molecular docking study of the lead molecule was also performed to determine hypothetical interactions in the enzyme-binding cavity. These findings suggest that <b>IHC3</b> is a strong, specific, and reversible MAO-B inhibitor that can be used to treat neurological diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Manoharan", "ForeName": "Amritha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea."}], "LastName": "Oh", "ForeName": "Jong Min", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Benny", "ForeName": "Feba", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Kumar", "ForeName": "Sunil", "Initials": "S"}, {"Identifier": ["0000-0001-9035-5638"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt."}], "LastName": "Abdelgawad", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": ["0000-0002-9179-4373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Ghoneim", "ForeName": "Mohammed M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "Shaker", "ForeName": "Mohamed E", "Initials": "ME"}, {"Identifier": ["0000-0002-0814-1743"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh 11597, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Anatomy, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "El-Sherbiny", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Science, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia."}], "LastName": "Almohaimeed", "ForeName": "Hailah M", "Initials": "HM"}, {"Identifier": ["0000-0002-2944-7856"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Graphic Era Hill University, Dehradun 248002, India."}], "LastName": "Gahtori", "ForeName": "Prashant", "Initials": "P"}, {"Identifier": ["0000-0002-7203-3712"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea."}], "LastName": "Kim", "ForeName": "Hoon", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Mathew", "ForeName": "Bijo", "Initials": "B"}], "GrantList": [{"GrantID": "No. 02/90/2022-23/RP/MN", "Agency": "Indian Council of Social Science Research (ICSSR), India to\u00a0Bijo Mathew", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "82X95S7M06", "NameOfSubstance": "Isatin"}, {"RegistryNumber": "9MV14S8G3E", "NameOfSubstance": "Pargyline"}, {"RegistryNumber": "0", "NameOfSubstance": "Dopamine Agents"}, {"RegistryNumber": "EC 1.4.3.4", "NameOfSubstance": "Monoamine Oxidase"}, {"RegistryNumber": "0", "NameOfSubstance": "Antipsychotic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": [], "DescriptorName": "Isatin"}, {"QualifierName": [], "DescriptorName": "Microwaves"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Pargyline"}, {"QualifierName": [], "DescriptorName": "Pharmacophore"}, {"QualifierName": [], "DescriptorName": "Neuroblastoma"}, {"QualifierName": [], "DescriptorName": "Dopamine Agents"}, {"QualifierName": [], "DescriptorName": "Monoamine Oxidase"}, {"QualifierName": [], "DescriptorName": "Antipsychotic Agents"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sonawane R.P., Tripathi R.R. The chemistry and synthesis of 1H-indole-2,3-dione (isatin) and its derivatives. Int. Lett. Chem. Phys. Astron. 2013;7:30\u201336. doi: 10.56431/p-8lif75.", "ArticleIdList": ["10.56431/p-8lif75"]}, {"Citation": "Medvedev A., Igosheva N., Crumeyrolle-Arias M., Glover V. Isatin: Role in stress and anxiety. Stress. 2005;8:175\u2013183. doi: 10.1080/10253890500342321.", "ArticleIdList": ["10.1080/10253890500342321", "16236622"]}, {"Citation": "Khan F.A., Maalik A. Advances in pharmacology of isatin and its derivatives: A review. Trop. J. Pharm. Res. 2015;14:1937\u20131942. doi: 10.4314/tjpr.v14i10.28.", "ArticleIdList": ["10.4314/tjpr.v14i10.28"]}, {"Citation": "Grewal A.S. Isatin derivatives with several biological activities. J. Int. Pharm. Res. 2014;6:1\u20137."}, {"Citation": "Da Silva J.F., Garden S.J., Pinto A.C. The chemistry of isatins: A review from 1975 to 1999. J. Braz. Chem. Soc. 2001;12:273\u2013324. doi: 10.1590/S0103-50532001000300002.", "ArticleIdList": ["10.1590/S0103-50532001000300002"]}, {"Citation": "Varun, Sonam, Kakkar R. Isatin and its derivatives: A survey of recent syntheses, reactions, and applications. Med. Chem. Comm. 2019;10:351\u2013368. doi: 10.1039/C8MD00585K.", "ArticleIdList": ["10.1039/C8MD00585K", "PMC6438150", "30996856"]}, {"Citation": "Mathur G., Nain S. Recent advancement in synthesis of isatin as anticonvulsant agents: A review. Med. Chem. 2014;4:417\u2013427."}, {"Citation": "Nath R., Pathania S., Grover G., Akhtar M.J. Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship. J. Mol. Struct. 2020;1222:128900. doi: 10.1016/j.molstruc.2020.128900.", "ArticleIdList": ["10.1016/j.molstruc.2020.128900"]}, {"Citation": "Kumar S., Nair A.S., Abdelgawad M.A., Mathew B. Exploration of the detailed structure\u2013activity relationships of isatin and their isomers as monoamine oxidase inhibitors. ACS Omega. 2022;7:16244\u201316259. doi: 10.1021/acsomega.2c01470.", "ArticleIdList": ["10.1021/acsomega.2c01470", "PMC9118264", "35601305"]}, {"Citation": "\u017dari S., Kudrjashova M., Pehk T., Lopp M., Kanger T. Remote activation of the nucleophilicity of isatin. Org. Lett. 2014;16:1740\u20131743. doi: 10.1021/ol500421k.", "ArticleIdList": ["10.1021/ol500421k", "24611877"]}, {"Citation": "Popp P.D. The chemistry of isatin. Chem. Isatin. 1975;18:1\u201358."}, {"Citation": "Singh G.S., Desta Z.Y. Isatins as privileged molecules in design and synthesis of spiro-fused cyclic frameworks. Chem. Rev. 2012;112:6104\u20136155. doi: 10.1021/cr300135y.", "ArticleIdList": ["10.1021/cr300135y", "22950860"]}, {"Citation": "Deng J., Zhang S., Ding P., Jiang H., Wang W., Li J. Facile creation of 3-indolyl-3-hydroxy-2-oxindoles by an organocatalytic enantioselective friedel-crafts reaction of indoles with isatins. Adv. Synth. Catal. 2010;352:833\u2013838. doi: 10.1002/adsc.200900851.", "ArticleIdList": ["10.1002/adsc.200900851"]}, {"Citation": "Chen J.-R., Liu X.-P., Zhu X.-Y., Li L., Qiao Y.-F., Zhang J.-M., Xiao W.-J. Organocatalytic asymmetric aldol reaction of ketones with isatins: Straightforward stereoselective synthesis of 3-alkyl-3-hydroxyindolin-2-ones. Tetrahedron. 2007;63:10437\u201310444. doi: 10.1016/j.tet.2007.08.003.", "ArticleIdList": ["10.1016/j.tet.2007.08.003"]}, {"Citation": "Guo H. Isatin derivatives and their anti-bacterial activities. Eur. J. Med. Chem. 2019;164:678\u2013688. doi: 10.1016/j.ejmech.2018.12.017.", "ArticleIdList": ["10.1016/j.ejmech.2018.12.017", "30654239"]}, {"Citation": "Pakravan P., Kashanian S., Khodaei M.M., Harding F.J. Biochemical and pharmacological characterization of isatin and its derivatives: From structure to activity. Pharmacol. Rep. 2013;65:313\u2013335. doi: 10.1016/S1734-1140(13)71007-7.", "ArticleIdList": ["10.1016/S1734-1140(13)71007-7", "23744416"]}, {"Citation": "Pandeya S.N., Smitha S., Jyoti M., Sridhar S.K. Biological activities of isatin and its derivatives. Acta Pharm. 2005;55:27\u201346.", "ArticleIdList": ["15907222"]}, {"Citation": "Raza C., Anjum R., Shakeel N.U.A. Parkinson\u2019s disease: Mechanisms, translational models and management strategies. Life Sci. 2019;226:77\u201390. doi: 10.1016/j.lfs.2019.03.057.", "ArticleIdList": ["10.1016/j.lfs.2019.03.057", "30980848"]}, {"Citation": "Chopade P., Chopade N., Zhao Z., Mitragotri S., Liao R., Chandran Suja V. Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioeng. Transl. Med. 2023;8:e10367. doi: 10.1002/btm2.10367.", "ArticleIdList": ["10.1002/btm2.10367", "PMC9842041", "36684083"]}, {"Citation": "V\u00e1zquez-V\u00e9lez G.E., Zoghbi H.Y. Parkinson\u2019s disease genetics and pathophysiology. Annu. Rev. Neurosci. 2021;44:87\u2013108. doi: 10.1146/annurev-neuro-100720-034518.", "ArticleIdList": ["10.1146/annurev-neuro-100720-034518", "34236893"]}, {"Citation": "Yamada M., Yasuhara H. Clinical pharmacology of MAO inhibitors: Safety and future. Neurotoxicology. 2004;25:215\u2013221. doi: 10.1016/S0161-813X(03)00097-4.", "ArticleIdList": ["10.1016/S0161-813X(03)00097-4", "14697896"]}, {"Citation": "Riederer P., Laux G. MAO-inhibitors in Parkinson\u2019s disease. Exp. Neurobiol. 2011;20:1\u201317. doi: 10.5607/en.2011.20.1.1.", "ArticleIdList": ["10.5607/en.2011.20.1.1", "PMC3213739", "22110357"]}, {"Citation": "Justo L.A., Dur\u00e1n R., Alfonso M., Fajardo D., Faro L.R.F. Effects and mechanism of action of isatin, a MAO inhibitor, on in vivo striatal dopamine release. Neurochem. Int. 2016;99:147\u2013157. doi: 10.1016/j.neuint.2016.06.012.", "ArticleIdList": ["10.1016/j.neuint.2016.06.012", "27374845"]}, {"Citation": "Tavari M., Malan S.F., Joubert J. Design, synthesis, biological evaluation and docking studies of sulfonyl isatin derivatives as monoamine oxidase and caspase-3 inhibitors. Med. Chem. Comm. 2016;7:1628\u20131639. doi: 10.1039/C6MD00228E.", "ArticleIdList": ["10.1039/C6MD00228E"]}, {"Citation": "Tripathi R.K.P., Krishnamurthy S., Ayyannan S.R. Discovery of 3-hydroxy-3-phenacyloxindole analogues of isatin as potential monoamine oxidase inhibitors. Chem. Med. Chem. 2016;11:119\u2013132. doi: 10.1002/cmdc.201500443.", "ArticleIdList": ["10.1002/cmdc.201500443", "26592797"]}, {"Citation": "Manley-King C.I., Bergh J.J., Petzer J.P. Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues. Bioorg. Med. Chem. 2011;19:261\u2013274. doi: 10.1016/j.bmc.2010.11.028.", "ArticleIdList": ["10.1016/j.bmc.2010.11.028", "21134756"]}, {"Citation": "Tripathi R.K.P., Rai G.K., Ayyannan S.R. Exploration of a library of 3,4-(methylenedioxy)aniline-derived semicarbazones as dual inhibitors of monoamine oxidase and acetylcholinesterase: Design, synthesis, and evaluation. Chem. Med. Chem. 2016;11:1145\u20131160. doi: 10.1002/cmdc.201600128.", "ArticleIdList": ["10.1002/cmdc.201600128", "27135466"]}, {"Citation": "Tripathi R.K.P., Ayyannan S.R. Design, synthesis, and evaluation of 2-amino-6-nitrobenzothiazole-derived hydrazones as mao inhibitors: Role of the methylene spacer group. Chem. Med. Chem. 2016;11:1551\u20131567. doi: 10.1002/cmdc.201600202.", "ArticleIdList": ["10.1002/cmdc.201600202", "27332045"]}, {"Citation": "Vishnu M.S., Pavankumar V., Kumar S., Raja A.S. Experimental and computational evaluation of piperonylic acid derived hydrazones bearing isatin moieties as dual inhibitors of cholinesterases and monoamine oxidases. Chem. Med. Chem. 2019;14:1359\u20131376. doi: 10.1002/cmdc.201900277.", "ArticleIdList": ["10.1002/cmdc.201900277", "31177620"]}, {"Citation": "Dorri M., Hashemitabar S., Hosseinzadeh H. Cinnamon (cinnamomum zeylanicum) as an antidote or a protective agent against natural or chemical toxicities: A review. Drug Chem. Toxicol. 2018;41:338\u2013351. doi: 10.1080/01480545.2017.1417995.", "ArticleIdList": ["10.1080/01480545.2017.1417995", "29319361"]}, {"Citation": "Wang L., Hou Y., Yi D., Ding B., Zhao D., Wang Z., Zhu H., Liu Y., Gong J., Assaad H., et al. Beneficial roles of dietary oleum cinnamomi in alleviating intestinal injury. Front. Biosci. Landmark. 2015;20:814\u2013828.", "ArticleIdList": ["25553481"]}, {"Citation": "Angelopoulou E., Paudel Y.N., Piperi C., Mishra A. Neuroprotective potential of cinnamon and its metabolites in parkinson\u2019s disease: Mechanistic insights, limitations, and novel therapeutic opportunities. J. Biochem. Mol. Toxicol. 2021;35:e22720. doi: 10.1002/jbt.22720.", "ArticleIdList": ["10.1002/jbt.22720", "33587308"]}, {"Citation": "Hajinejad M., Ghaddaripouri M., Dabzadeh M., Forouzanfar F., Sahab-Negah S. Natural cinnamaldehyde and its derivatives ameliorate neuroinflammatory pathways in neurodegenerative diseases. Biomed. Res. Int. 2020;2020:1034325. doi: 10.1155/2020/1034325.", "ArticleIdList": ["10.1155/2020/1034325", "PMC7683109", "33274192"]}, {"Citation": "Bae W.-Y., Choi J.-S., Jeong J.-W. The Neuroprotective effects of cinnamic aldehyde in an mptp mouse model of parkinson\u2019s disease. Int. J. Mol. Sci. 2018;19:551. doi: 10.3390/ijms19020551.", "ArticleIdList": ["10.3390/ijms19020551", "PMC5855773", "29439518"]}, {"Citation": "Mathew B., Oh J.M., Abdelgawad M.A., Khames A., Ghoneim M.M., Kumar S., Nath L.R., Sudevan S.T., Parambi D.G.T., Agoni C., et al. Conjugated dienones from differently substituted cinnamaldehyde as highly potent monoamine oxidase-b inhibitors: Synthesis, biochemistry, and computational chemistry. ACS Omega. 2022;7:8184\u20138197. doi: 10.1021/acsomega.2c00397.", "ArticleIdList": ["10.1021/acsomega.2c00397", "PMC8908507", "35284720"]}, {"Citation": "Viegas-Junior C., Danuello A., Bolzani V.D.S., Barreiro E.J., Fraga C.A.M. Molecular hybridization: A useful tool in the design of new drug prototypes. Curr. Med. Chem. 2007;14:1829\u20131852. doi: 10.2174/092986707781058805.", "ArticleIdList": ["10.2174/092986707781058805", "17627520"]}, {"Citation": "Dyniewicz J., Lipi\u0144ski P.F.J., Kosson P., Le\u015bniak A., Bochy\u0144ska-Czy\u017c M., Muchowska A., Tourw\u00e9 D., Ballet S., Misicka A., Lipkowski A.W. Hydrazone linker as a useful tool for preparing chimeric peptide/nonpeptide bifunctional compounds. ACS Med. Chem. Lett. 2017;8:73\u201377. doi: 10.1021/acsmedchemlett.6b00381.", "ArticleIdList": ["10.1021/acsmedchemlett.6b00381", "PMC5238479", "28105278"]}, {"Citation": "Abdelrhman E.M., El-Shetary B.A., Shebl M., Adly O.M.I. Coordinating behavior of hydrazone ligand bearing chromone moiety towards Cu(II) ions: Synthesis, spectral, density functional theory (DFT) calculations, antitumor, and docking studies. Appl. Organomet. Chem. 2021;35:e6183. doi: 10.1002/aoc.6183.", "ArticleIdList": ["10.1002/aoc.6183"]}, {"Citation": "Gebretsadik T., Yang Q., Wu J., Tang J. Hydrazone based spin crossover complexes: Behind the extra flexibility of the hydrazone moiety to switch the spin state. Coord. Chem. Rev. 2021;431:213666. doi: 10.1016/j.ccr.2020.213666.", "ArticleIdList": ["10.1016/j.ccr.2020.213666"]}, {"Citation": "Kumar S., Jayan J., Manoharan A., Benny F., Abdelgawad M.A., Ghoneim M.M., El-Sherbiny M., Thazhathuveedu Sudevan S., Aneesh T.P., Mathew B. Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation. J. Biomol. Struct. Dyn. 2023:1\u201313. doi: 10.1080/07391102.2023.2214216.", "ArticleIdList": ["10.1080/07391102.2023.2214216", "37261844"]}, {"Citation": "Knez D., Hrast M., Frlan R., Pi\u0161lar A., \u017dakelj S., Kos J., Gobec S. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library. Bioorg. Chem. 2022;119:105581. doi: 10.1016/j.bioorg.2021.105581.", "ArticleIdList": ["10.1016/j.bioorg.2021.105581", "34990933"]}, {"Citation": "Krishna A., Lee J., Kumar S., Sudevan S.T., Uniyal P., Pappachen L.K., Kim H., Mathew B. Inhibition of monoamine oxidases by benzimidazole chalcone derivatives. Appl. Biol. Chem. 2023;66:37. doi: 10.1186/s13765-023-00795-1.", "ArticleIdList": ["10.1186/s13765-023-00795-1"]}, {"Citation": "Prinsloo I.F., Petzer J.P., Cloete T.T., Petzer A. The evaluation of isatin analogues as inhibitors of monoamine oxidase. Chem. Biol. Drug Des. 2023:27. doi: 10.1111/cbdd.14304.", "ArticleIdList": ["10.1111/cbdd.14304", "37500571"]}, {"Citation": "Cheng K., Li S., Lv X., Tian Y., Kong H., Huang X., Duan Y., Han J., Xie Z., Liao C. Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure. Bioorg. Med. Chem. Lett. 2019;29:1012\u20131018. doi: 10.1016/j.bmcl.2019.02.008.", "ArticleIdList": ["10.1016/j.bmcl.2019.02.008", "30792039"]}, {"Citation": "Schnell S., Maini P.K. A century of enzyme kinetics: Reliability of the Km and Vmax estimates? Theor. Popul. Biol. 2003;8:169\u2013187."}, {"Citation": "Lee H.W., Ryu H.W., Kang M.-G., Park D., Oh S.-R., Kim H. Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg. Med. Chem. Lett. 2016;26:4714\u20134719. doi: 10.1016/j.bmcl.2016.08.044.", "ArticleIdList": ["10.1016/j.bmcl.2016.08.044", "27575476"]}, {"Citation": "Oh J.M., Jang H.-J., Kim W.J., Kang M.-G., Baek S.C., Lee J.P., Park D., Oh S.-R., Kim H. Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B. Int. J. Biol. Macromol. 2020;151:441\u2013448. doi: 10.1016/j.ijbiomac.2020.02.144.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.02.144", "32087226"]}, {"Citation": "Lee H.W., Ryu H.W., Kang M.-G., Park D., Lee H., Shin H.M., Oh S.-R., Kim H. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi. Int. J. Biol. Macromol. 2017;97:598\u2013605. doi: 10.1016/j.ijbiomac.2017.01.080.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.01.080", "28109809"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "19"}, {"Year": "2023", "Month": "8", "Day": "4"}, {"Year": "2023", "Month": "8", "Day": "19"}, {"Year": "2023", "Month": "8", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "10", "Minute": "44"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "1", "Minute": "25"}, {"Year": "2023", "Month": "8", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["37630420", "PMC10458360", "10.3390/molecules28166167", "molecules28166167"]}}], "PubmedBookArticle": []}